Standard BioTools (LAB) Earnings Analysis
Standard BioTools (LAB) next reports earnings on 2026-08-10, consensus EPS -0.01 USD. Last quarter (2025-08-11) it beat with EPS -0.04 USD vs -0.04 USD est (0%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -3.27.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does LAB next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.01 USD |
| Revenue estimate | 0.02B |
LAB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-11 | -0.04 USD | -0.04 USD | 0% | Beat |
| 2025-02-26 | -0.05 USD | -0.07 USD | +28.6% | Beat |
| 2024-10-30 | -0.05 USD | -0.08 USD | +37.5% | Beat |
| 2024-07-31 | -0.08 USD | -0.06 USD | -33.3% | Miss |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
LAB valuation and analyst view
| Trailing P/E | -3.27 |
|---|---|
| Trailing EPS | -0.24236 USD |
| Price / book | 0.57 |
| Dividend yield | 0.00% |
| Market cap | 0.33B |
| Analyst consensus | Buy (6 buy / 4 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Standard BioTools (LAB)'s next earnings date?
Standard BioTools is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.01 USD and revenue estimate of 0.02B.
Did LAB beat earnings last quarter?
In its 2025-08-11 report, LAB posted EPS of -0.04 USD versus a -0.04 USD estimate — a beat of 0%.
What is LAB's earnings track record?
Over the last 4 reported quarters with consensus data, LAB beat estimates 3 times (75%).
What is LAB's current P/E ratio and EPS?
LAB trades at a trailing P/E of -3.27 on trailing EPS of -0.24235835982297876 USD.
What do analysts rate LAB?
Analyst consensus is "Buy" across 10 ratings (0 strong buy, 6 buy, 4 hold, 0 sell, 0 strong sell).